Archive
May 29, 2013
NDC data on claims will play a significant role in 2013. Previous News and Updates and Blue Review articles have emphasized the importance of including NDCs when drugs are billed on professional/ancillary electronic (ANSI 837P) and paper (CMS-1500) claims.
Email Updates
Leave Feedback